Boston Scientific is the latest company to make a big investment in the fast-growing remote diagnostics and services market with an agreement to buy ambulatory cardiac monitoring company Preventice Solutions for $925m in cash and up to $300m in potential milestones.
Boston Scientific Bets Big On Monitoring; Buys Preventice For Up To $1.25Bn
The deal is the fourth major acquisition in the remote monitoring market in the last five weeks after Philips acquired BioTelemetry and Capsule and Hillrom bought Bardy Diagnostics.
